There was an extra 155% shares issued, per my post yesterday in the other thread.
There were 135m existing, plus 150m issued via the institutional placement (including oversubscription from Bain), plus the 50-70m issued to existing retail holders. Multiply the current share price by around 2.5 to 2.6x and you have your pre-COVID 'like-for-like' comparison in terms of the share price (e.g. today, circa $8.10-8.40)
The extent of dilution has been grossly misunderstood by many, and I say that as someone who has held this stock since 2013 (selling bits here and there, as I did yesterday).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.50 |
Change
-0.020(0.44%) |
Mkt cap ! $1.626B | |||
| Open | High | Low | Value | Volume |
| $4.50 | $4.52 | $4.43 | $18.37M | 4.092M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 424962 | $4.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.52 | 21617 | 5 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| WEB (ASX) Chart |